Immunosuppression vs. Infection Flashcards

1
Q

How would you manage this patient with recurrent infection who is on chronic immunosuppression? (initial spiel for any case before the “balancing”)

A

Acknowledge: “this is a difficult Mx issue - one side you have the risk of significant end-organ damage posed by a chronic condition (or rejection) but on the other side there is a risk of increased mortality from unremitting infection.”

“The most important thing is to Establish the risk associated with each variable in question

  • Infection
    • how acute is the problem? - note that chronic deep-seated infections such as osteomyelitis may be unable to be controlled without lessening immunosuppression
    • how severe is the problem? - are there markers of end-organ dysfunction?
    • can we treat the infection without decreasing the immunosuppression - some infections are exquisitely immunosensitive, such as PML, BK virus
  • ImmSx
    • how active is the condition - is there an active need for immunosupression
    • has it been severe in the past - ie predicting a severe phenotype

“I will always discuss the risk and benefit with the patient”

“I would ensure that modifiable risk factors are addressed”

Non-pharm

  • Vaccination - seasonal flu, Pneumovax
  • Smoking cessation
  • Optmise nutrition
  • Avoid high-risk exposures

Pharm

  • Prophylactic antimicrobials - if not given already
  • Investigate for immunodeficiency: e.g. rule out HIV, autoimmune leukopaenia, hypogammaglobulinemia, consider IVIG if deficiency present
  • Ensure patient is not over immunosuppressed: would like to review drug levels
  • Ensure no significant drug interaction - e.g. MTX and Bactrim***
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

So what is your approach in balancing the immunosuppression vs. infection in this particular case once you have dealt with modifiable risk factors?

A

Assess the risk of acute infection

  • How acute & severe is it (is there _end-organ damag_e)
  • Wherever possible, I’d prefer to treat the infection without decreasing the immunosuppression (reasonable if acute but not-so-severe infection)
  • However, this may not be possible if the infection is chronic deep-seated (e.g. OM), severe or ImmSx associated infections such as BK, PML (exquisitely immunosensitive)

Assess the risk posed by decreasing the ImmSx

  • How active/severe is condition - clinically and biochemically
  • Is there an active need for immSx? If not active, maybe reasonable to decrease/WH it
  • Note that this patient has had (severe vs. mild disease only) previously, so I would be very cautious about decreasing the immSx
  • Will consider alternative ImmSx regime
  • In any case, will need to carefully monitor for any evidence of active disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MTX and Bactrim together - thoughts?

A

They are both inhibitors of folic acid metabolism - hence the risk of BM toxicity is high.

Also Bactrim decreases renal excretion of MTX → potential toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which micro-organisms are you worried about the most in hyposplenism or asplenic patients? (4)

A

Overwhelming infection by encapsulated organisms.

  1. Streptococcus pneumonia (40-60%)
  2. Neisseria meningitidis
  3. Haemophilus influenzae
  4. Malaria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If splenic function is in doubt, what can you check for?

A

Howell-Jolly bodies in blood film

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which vaccines are recommended for asplenic patients? (4)

A
  1. 5 yearly pneumococcal
  2. 5-yearly conjugated meningococcal ACWY vaccine
  3. One-off Haemophilus influenza vaccine
  4. Yearly influenza vaccie
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the usual duration of prophylactic ABx following splenectomy and when would you recommend life-long prophylaxis? (3)

A

Amoxicillin 250mg or Cephalosporin or Macrolide.

3 years except

  1. Have survived overwhelming infection
  2. Significant immunocompromisation
  3. Haematological malignancy or GvHD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the causes of Hypogammaglobulinaemia? (6)

A

Decreased production

  • Congenital (primary)
  • Drugs - immunosuppressives, anti-inflammatories (e.g. steroids), anti-epileptics, Rituximab or B-cell acting drugs
  • Malignancy - CLL, lymphoma, myeloma

Increased loss

  • Nephrotic syndrome
  • Protein-losing enteropathies
  • Trauma/burns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which infections are you particularly worried about in patients with Hypogammaglobulinaemia?

A

Encapsulated bacteria

Recurrent sino-pulmonary infections → bronchiectasis

Chronic diarrhoea (e.g. Giardia, campylobacter, rota)

Invasive infections - deep seated infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Longcase patients on chemo or haematological patient with MF or aplastic anaemia - comment/spiel?

A

“I am aware that these patients are at risk of prolonged neutropaenia which increases the risk of more severe bacterial infection and Fungal infection”

“I would educate patient WRT their response to febrile illness, has a number to call (e.g. onc CNC) and present to ED”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What test would you send off for suspected meningitis/encephalitis in immunocompromised patients?

A

Cryptococcal Ag + culture

Mycobacterial PCR/culture

Viral PCR - CMV, EBV, VZV, HSV, Enterovirus, JCV

MCS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What additional test would you send off from the stool if you suspect GI infection in immunocompromised? (3)

A

Other than stool cultures and viral PCRs, I would send off

  • Strongyloides serology + microscopy of faeces
  • Cryptosporidium
  • Microsporidium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In which patient groups would you consider PJP prophylaxis? other than solid/stem cell transplants or HIV patients? (3)

A

Steroids >20mg/day + other cause of ImmSx (e.g. cyclophosphamide)

Primary immunodeficiencies

High-dose steroids + TNF inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Good spiel to say when the dose of immSx are quite high

A

I note that the patient is on significant dose of ImmSx - I suspect the graft funciton may be less than adequate, which puts them at risk of not only the opportunistic infections but also more severe infection from common community acquired infections”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is your cut-off for calling CMV syndrome/disease?

A

Blood CMV DNA PCR copies/mL

In general no widely accepted PCR thresholds that differentiate among latent infection, low-level active infection and CMV disease and clinical judgement must be used when evaluating PCR results

CMV syndrome: mean viral load ~10,000

CMV tissue invasive disease mean viral load ~20,000

Histological examination of biopsied tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How would you treat active CMV with detectable CMV viraemia?

A

Depends on risk profile WRT decreasing immSx

Monitor CMV PCR - weekly

If CMV disease, stop anti-metabolite

Ganciclovir (severe) or valganciclovir (less severe)

Duration: induction 2-4 weeks, followed by 1-3 months to prevent relapse (oral Valgan)

17
Q

Screening protocol for BK virus in renal transplant?

A

Quantitative BK PCR monthly for 1st 6 months

3 monthly for 2 years post-transplant

then whenever the renal impairment occur

18
Q

What is one of the biggest problem trying to treat transplant patients on CNIs who develops TB?

A

Drug interaction between Rifamycin (Rifampicin) + tacro/CsA/Rapacymins - sirolomus, everolimus.

Rifampicin drugs decreases the level of these drugs → increasing risk of rejections

So the dose of drugs must be increased, approximately to 3-5 folds, so involve renal physicians and ID early.

19
Q

Haem/Onc patients infection risk spiel? (5)

A

I am concerned about this patient’s long term infection risk given the risk of

  • deficient cell-mediated immunity
  • Hypogammaglobulinaemia (especially B-cell malignancies)
  • Hyposplenism/splenectomy
  • IV lines/port
  • High-risk for colonisation with resistant organisms
20
Q

What is your approach for managing the risk of infection in this patient about to go BMT? (4) - especially allogenic as they are at the highest risk.

A
  1. Screen for infection:
  • CMV, EBV, VAV, HIV, Hepatitis, Quntiferon, urine, CXR, directed by symptoms.
  • Strongyloides screen in faeces and treat with ivermectin.
  1. Prophylactic antimicrobial therapy:
  • Ciprofloxacin pre-engraftment
  • Antifungal in high-risk
  • Bactrim (also effective for Toxo, Nocardia, Listeria)
  • HSV 1/2 seropositive - acyclovir or valacyclovir
  • VZV seropositive - valacyclovir 12 months
  • VZV non-immune - avoid contact with chickenpox, Immunoglobulin if exposed
  • CMV - treat those with viraemia
  • Allogenic with chronic GvHD: Penicillin prophylaxis against encapsulated bacteria
  1. Vaccination
  2. Regular follow-up: Hx, exam, directed investigations, having low-threshold for appropriate investigations and early treatment.
21
Q

Which groups of people require Hepatitis B/C vaccination as an adult? (5)

A

HIV (need to receive 4 high dose vaccine)

Patients on haemodialysis (again larger than standard dose)

HSCT (stem cell transplants)

Immunocompromised

Chronic liver disease